A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
To assess whether adding LCL161 to weekly paclitaxel enhances the efficacy of paclitaxel in women with triple negative breast cancer whose tumors are positive for a defined pattern of gene expression
Epistemonikos ID: 01c980453f203292ea5c9f32ce37bca29be2ca2a
First added on: May 11, 2024